The induction of immunogenic cell death by type II anti-CD20 monoclonal antibodies has mechanistic differences compared with type I rituximab

Eleanor J. Cheadle, Lauren Sidon, Simon J. Dovedi, Monique H M Melis, Waleed Alduaij, Tim M. Illidge, Jamie Honeychurch

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)842-845
    Number of pages3
    JournalBritish Journal of Haematology
    Issue number6
    Publication statusPublished - Sept 2013


    • CD20
    • Cell death
    • DAMP
    • Lymphoma
    • Monoclonal antibody

    Cite this